Literature DB >> 23226779

Number of metastasis-positive lymph node stations is a simple and reliable prognostic factor following surgery in patients with esophageal cancer.

Shinsuke Takeno1, Shin-Ichi Yamashita, Satoshi Yamamoto, Yoshiaki Takahashi, Toshihiko Moroga, Katsunobu Kawahara, Toyoo Shiroshita, Ippei Yamana, Kenji Maki, Yuichi Yamashita.   

Abstract

The aim of this study was to evaluate the utility of lymph node metastasis classification based on the number of positive stations in patients undergoing surgical management of esophageal cancer. Of 257 patients who underwent curative esophagectomy, 126 patients with lymph node involvement underwent assessment of nodal metastasis mode according to the 7th edition of the TNM classification (UICC), and the Japanese Guidelines for the Clinical and Pathological Studies on Carcinoma of the Esophagus. Lymph node metastasis mode was divided into single station (S) and multi-station (M) groups. The S group was subclassified into single-node-single-station (SS) or multi-node-single-station (MS), and the M group was subclassified into multi-station in pN1 (2 metastasis positive nodes; MM-pN1) or multi-station in pN2 or 3 (MM-pN2,3) by TNM classification, multi-station-single-area (MMS) or multi-station-multi-areas (MMM). The correlation between prognosis and lymph node metastasis mode was assessed. A total of 47 patients were classified as S (MS, n=11; SS, n=36), and 79 patients were classified as M (MM-pN1, n=12; MM-pN2,3, n=67; MMM, n=55; MMS, n=24). Prognosis was poorer among the M- than in the S-classified patients (p=0.0035), whereas prognosis was not significantly different between the subgroups. In conclusion, lymph node metastasis classification based on the number of metastasis-positive stations is a useful predictor of prognosis in patients undergoing surgical management of esophageal cancer. This system relies on a simple classification method that combines the Japanese classification based on lymphatic spread and the TNM classification based on the number of positive lymph nodes.

Entities:  

Year:  2012        PMID: 23226779      PMCID: PMC3494111          DOI: 10.3892/etm.2012.705

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Esophageal cancer ranks among the ten most common cancers in the world, and lymph node metastasis is a critical determinant of poor prognosis for this cancer (1,2). Lymph node classification is based on the number of nodes with metastatic foci within the most recent (7th) edition of the tumor, node, metastasis (TNM) system of classification defined by the International Union Against Cancer (UICC) (3). This reflects a distinct prognostic difference from the 6th edition of these guidelines, in which nodal metastasis was graded as either present or absent. By contrast, the lymph node classification endorsed by the Japanese Society for Esophageal Disease is based on anatomical lymphatic spread to lymph node stations and is also useful for the assessment of prognosis (4). However, to date, there is no consensus as to which nodal classification system is the most useful for assessment of prognosis, although several other nodal classification have been proposed. The aim of this study was to examine the utility and feasibility of a novel metastatic node classification system that combines the intensity of node metastasis (represented by the TNM classification system) and anatomical lymphatic spread (represented by the Japanese classification system) for the assessment of prognosis of patients undergoing surgical management for esophageal cancer.

Patients and methods

Patients

Data were obtained from 257 patients (224 males and 33 females; mean age, 64.0 years) who underwent transthoracic esophagectomy via the right transthoracic route for esophageal cancer without preoperative chemotherapy or radiotherapy between January 1991 and December 2008. Data were collected and analyzed retrospectively, and all patients employed in the analysis were followed until death or until December 2010 (i.e., at least 2 years after surgery). Clinicopathological characteristics including tumor invasion, node metastasis and stage were based on the TNM classification, 7th edition, by the International Union Against Cancer, and on the Japanese Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. Lymph node station spread was determined according to the Japanese classification system (3,4).

Classification of lymph node status

The mode of lymph node metastasis was divided into two groups: single-station (S) and multi-station (M). In addition, the S group was subclassified into a single-node-single-station (SS) group, in which lymph node metastasis was detected in only one node, and a multi-node-single-station (MS) group, in which lymph node metastasis was detected in two or more nodes within a single lymph node station. Furthermore, the M group was also subclassified into a multi-station in pN1 (two metastasis-positive nodes) by TNM classification (MM-pN1) group, a multi-station in pN2 or 3 in TNM classification (MM-pN2,3) group, a multi-station-single-area (MMS) group, in which the metastasis-positive lymph node station was localized to the cervical, thoracic or abdominal area, and a multi-station-multi-area (MMM) group, in which metastasis-positive nodes were present in two or more of these areas.

Statistical analysis

The correlation between prognosis and lymph node metastasis mode was assessed. The Kaplan-Meier method by Wilcoxon test was used to assess prognosis after surgery. A p-value <0.05 was considered to indicate statistical significance in each analysis.

Results

Patient characteristics are shown in Table I. Of the 257 patients, 131 (51.0%) had no lymph node metastasis. Of the 126 patients with lymph node metastasis, 55 patients (43.7%) were classified as pN1, 46 (36.5%) were classified as pN2, and 25 (19.8%) were classified as pN3 by pN category of the TNM classification based on the number of metastasis-positive lymph nodes. By contrast, 42 patients (33.3%) were classified as pN1, 46 (36.5%) were classified as pN2, 19 (15.1%) were classified as pN3 and 19 (15.1%) were classified as pN4 by the Japanese classification system based on lymphatic spread to lymph node station. Disease-specific survivals according to TNM and Japanese classifications are shown in Fig. 1A and B, and both classifications revealed significant prognostic differences between pN categories (p<0.0001).
Table I

Characteristics of the patients undergoing thoracoscopic surgery for esophageal cancer.

CharacteristicNo. of patients
Age (years)64 (36–84)
Gender
  Male224
  Female33
Tumor location
  Upper thoracic32
  Middle thoracic143
  Lower thoracic82
Histology
  Squamous cell carcinoma228
  Adenosquamous carcinoma5
  Adenocarcinoma9
  Basaloid carcinoma10
  Spindle cell carcinoma1
  Neuroendocrine carcinoma1
  Small cell carcinoma2
  Undifferentiated carcinoma1
Tumor depth (pT)
  in situ5
  1116
  235
  399
  42
Lymph node metastasis (TNM classification)
  0131
  155
  246
  325
Lymph node metastasis (Japanese classification)
  0131
  142
  246
  319
  419
Lymphatic vessel invasion
  Negative108
  Positive149
Blood vessel invasion
  Negative179
  Positive78
Figure 1

Survival based on the lymph node metastasis category of (A) TNM and (B) Japanese classifications.

Of the 126 patients who were node metastasis-positive, 47 (37.3%) were classified as S group, and 79 patients (62.7%) were classified as M group. Among the S-group patients, 11 (23.4%) were classified as the MS group, and 36 (76.6%) were classified as the SS group. Of the M group patients, 12 patients (15.2%) were classified as MM-pN1, 67 patients (84.8%) were classified as MM-pN2,3. Using another system to subdivide the M group, 55 patients (69.6%) were classified as MMM group, and 24 (30.4%) were classified as MMS group. In the present lymph node metastasis classification system, M-group patients preferentially comprised those with cancer arising from the lower or upper thoracic esophagus (p=0.036), cases with advanced invasion depth (p<0.0001), cases with lymphatic vessel invasion (p<0.0001) and cases with blood vessel invasion (p<0.0001) (Table II).
Table II

Correlation between lymphatic spread and clinicopathological factors.

Lymphatic spread
p-value
NegativeSingle stationMulti-station
Gender
  Male11641670.74
  Female15612
Age (years)62.865.265.4
Location
  Lower3517300.036
  Middle852137
  Upper11912
Tumor invasion (pT)
  Superficial (pTis, 1)95188<0.0001
  Advanced (pT2, 3)362971
Lymphatic vessel invasion
  Negative821610<0.0001
  Positive493169
Blood vessel invasion
  Negative1093436<0.0001
  Positive221343
Lymph node metastasis classification in the present study revealed a distinct prognostic significance (p<0.0001). For example, multiple-station metastasis was a significant negative prognostic parameter compared with single-station metastasis (p=0.0035) (Fig. 2). However, prognosis was similar when comparing the MS and SS groups (p=0.71) (Fig. 3). In the MS group, the number of positive lymph nodes ranged from 2 to 8 (mean was 3.09). Five cases with more than 3 positive nodes were included in the MS group, 4 cases were classified as pN2 and 1 case was classified as pN3 in the TNM classification. Furthermore, there was no significant difference in prognosis when comparing the MM-pN1 and MM-pN2,3 groups (p=0.16) or when comparing the MMM and MMS groups (p=0.25) (Figs. 4 and 5).
Figure 2

Survival based on the number of metastasis-positive lymphatic stations.

Figure 3

Survival of the patients with single metastasis-positive lymphatic stations. SS, single-station; MS, multi-station.

Figure 4

Survival of the patients with multi-metastasis-positive lymphatic stations. MM-pN1, multi-station in pN1; MM-pN2,3, multi-station in pN2 or 3.

Figure 5

Survival of the patients with multi-metastasis-positive lymph nodes. MMS, multi-station-single-area; MMM, multi-station-multi-area.

Notably, the association between prognosis and node metastasis classification in this study (p<0.0001) was similar to that between prognosis and lymph node involvement of the TNM and Japanese classification systems in the multivariate analysis including conservative clinicopathological prognostic parameters despite close interaction with each other (Table III).
Table III

Multivariate analysis of prognostic impact with other clinicopathological parameters.

Risk ratio95% Confidence intervalp-value
Tumor invasion (pT)4.4120.6989–15.360.049
Lymphatic vessel invasion0.69840.4915–0.96110.027
Blood vessel invasion1.0750.8291–1.3910.58
No. of positive LN stations1.9191.359–2.737<0.0001

LN, lymph node.

Discussion

TNM classification can be used to predict prognosis in patients with esophageal cancer according to cancer stage (3). In the 6th edition of the TNM classification, lymph node involvement is classified as either present or absent. However, the 7th edition of the TNM classification, published in 2010, incorporates the number of lymph nodes with metastatic involvement and may be a more accurate prognostic parameter. This revised system still does not acknowledge the anatomical lymphatic spread, which may limit its overall utility. Thus, the present study utilized the revised TNM system in combination with the Japanese classification, which does assess anatomical lymphatic spread of metastasis. This node classification has prognostic significance, but the lymph node station category can vary with tumor location despite having the same lymph node station (4). Therefore, the present study used a simple modification of this system, in which the pN category of the lymph node station is not determined in detail, but the location of lymph node station is still taken into account. In this study, patients with multi-station lymph node metastasis preferentially comprised those with cancer arising from the lower or upper thoracic esophagus (p= 0.036), cases with advanced invasion depth (p<0.0001), cases with lymphatic vessel invasion (p<0.0001) and cases with blood vessel invasion (p<0.0001). Lamb et al and Kim et al reported that multiple sentinel nodes were detected more frequently in patients with lower thoracic esophageal cancer, which may account for the implied finding that lower thoracic esophageal cancers are more prone to metastasize to multiple nodes or stations (5,6). However, there has been no previous report suggesting that upper thoracic esophageal cancers are associated with a higher metastasis-positive station. Concerning the correlation between tumor invasion and lymphatic spread, Feith et al reported that deeper tumor invasion was associated with the increased number of metastasis-positive lymph nodes in patients with Barrett's esophageal adenocarcinoma (7). By contrast, the present result, which took into account the number of stations, may be consistent with the previous findings despite the fact that the majority of cases in the present study consisted of squamous cell carcinoma. This indicates that deeper invasive cancer in the lower thoracic esophagus requires much more extended lymph node dissection regardless of the histological type of esophageal cancer. In the univariate analysis of the prognostic impact, the lymph node metastasis classification system utilized in the present study exhibited a distinct prognostic significance when comparing the S and M groups, and the M group exhibited less favorable prognosis following surgery. Several other lymph node classification systems have been proposed to predict outcomes in patients undergoing surgical management of esophageal cancer. For example, Roder et al, Eloubeidi et al and Wilson et al described the utility of involved lymph node ratios for predicting an unfavorable prognosis (8–10). Roder et al and Eloubeidi et al set the cut-off values at 20 and 10%, and the increased ratio of metastatic nodes revealed an unfavorable prognosis. However, when Wilson et al set the cut-off values at 25 and 50%, there was no difference in prognosis when comparing the two groups. Altorki et al suggested that the increased number of dissected lymph nodes in the context of extended lymphadenectomy resulted in a decreased positive node ratio and a more favorable prognosis (11). By contrast, Dhar et al reported that the longer diameter of the largest metastatic lymph node was a strong negative prognostic factor, whereas Komori et al emphasized that the size of the cancer nest in the lymph node, but not lymph node size, had a prognostic impact (12,13). These previous reports were limited by the fact that they only examined very limited lymph node metastatic mode parameters. However, the present study takes into account the number of positive nodes represented by the TNM classification and the anatomical lymphatic spread represented by the Japanese classification, which likely resulted in a stronger independent prognostic factor, even within multivariate analysis including conservative pathological parameters. Notably, there was no prognostic difference between the SS and MS groups in this study. This indicates that a favorable prognosis may occur when lymph node metastasis is limited to a single station, even in the context of pN2 or 3 status in the TNM classification. Furthermore, lymph node dissection may be very effective in cases with limited anatomical lymphatic spread (e.g., S group), since all cases employed in the present series were surgically resected with extended curative lymph node dissection. Prognosis was also similar when comparing MM-pN1 cases and MM-pN2,3 cases, which supports inclusion of these two subclassifications within the same M group. The results of the subgroup analysis also indicate that anatomical lymphatic spread and the number of metastasis-positive nodes play an important role in outcome following surgical treatment of esophageal cancer, although Kunisaki et al reported that the number of metastatic nodes provides a more accurate estimate of prognosis than the anatomical lymphatic spread (14). The lymph node metastasis classification system used in the present study was an independent prognostic parameter, even within multivariate analysis including conservative pathological parameters, such as tumor invasion depth and lymphatic or blood vessel invasion. This result suggests that this classification system is an effective alternative to the pN category in the TNM or Japanese classification. In conclusion, lymph node metastasis classification based on the number of metastasis-positive stations is a useful predictor of prognosis in patients undergoing surgical management of esophageal cancer. This system relies on a simple classification method that combines the Japanese classification based on lymphatic spread and the TNM classification based on the number of positive nodes.
  13 in total

Review 1.  Pattern of lymphatic spread of Barrett's cancer.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

2.  Estimates of the worldwide mortality from 25 cancers in 1990.

Authors:  P Pisani; D M Parkin; F Bray; J Ferlay
Journal:  Int J Cancer       Date:  1999-09-24       Impact factor: 7.396

3.  Sentinel node identification using technetium-99m neomannosyl human serum albumin in esophageal cancer.

Authors:  Hyun Koo Kim; SeungEun Kim; Jong Jae Park; Jae Min Jeong; Young Jae Mok; Young Ho Choi
Journal:  Ann Thorac Surg       Date:  2011-03-05       Impact factor: 4.330

4.  Estimates of the worldwide incidence of 25 major cancers in 1990.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

5.  Developing an appropriate staging system for esophageal carcinoma.

Authors:  Chikara Kunisaki; Hirotoshi Akiyama; Masato Nomura; Goro Matsuda; Yuichi Otsuka; Hidetaka Andrew Ono; Hiroshi Shimada
Journal:  J Am Coll Surg       Date:  2005-10-10       Impact factor: 6.113

6.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

7.  Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus.

Authors:  J D Roder; R Busch; H J Stein; U Fink; J R Siewert
Journal:  Br J Surg       Date:  1994-03       Impact factor: 6.939

8.  Prognostic significance of lymph node metastases and ratio in esophageal cancer.

Authors:  Matthew Wilson; Ernest L Rosato; Karen A Chojnacki; Inna Chervoneva; John C Kairys; Herbert E Cohn; Francis E Rosato; Adam C Berger
Journal:  J Surg Res       Date:  2007-08-28       Impact factor: 2.192

9.  Total number of resected lymph nodes predicts survival in esophageal cancer.

Authors:  Nasser K Altorki; Xi Kathy Zhou; Brendon Stiles; Jeffrey L Port; Subroto Paul; Paul C Lee; Madhu Mazumdar
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

10.  Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers.

Authors:  Takamichi Komori; Yuichiro Doki; Toshiyuki Kabuto; Osamu Ishikawa; Masahiro Hiratsuka; Yo Sasaki; Hiroaki Ohigashi; Kohei Murata; Terumasa Yamada; Isao Miyashiro; Masayuki Mano; Shingo Ishiguro; Shingi Imaoka
Journal:  J Surg Oncol       Date:  2003-01       Impact factor: 3.454

View more
  10 in total

1.  Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection.

Authors:  Mingjian Yang; Hongdian Zhang; Zhao Ma; Lei Gong; Chuangui Chen; Peng Ren; Xiaobin Shang; Peng Tang; Hongjing Jiang; Zhentao Yu
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 2.  Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.

Authors:  Harushi Udagawa; Masaki Ueno
Journal:  Ann Transl Med       Date:  2018-02

3.  Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.

Authors:  Michelle Kang Kim; Richard R P Warner; Stephen C Ward; Noam Harpaz; Sasan Roayaie; Myron E Schwartz; Steven Itzkowitz; Juan Wisnivesky
Journal:  Neuroendocrinology       Date:  2015-01-05       Impact factor: 4.914

Review 4.  Lymph node dissection for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

5.  Psoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-κB and PI3K/Akt signaling pathways.

Authors:  Zhiliang Jin; Wei Yan; Hui Jin; Changzheng Ge; Yanhua Xu
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

6.  The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.

Authors:  Xiao-Ling Xu; Wei-Hui Zheng; Shuang-Mei Zhu; An Zhao; Wei-Min Mao
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

7.  A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma.

Authors:  Zheng Lin; Weilin Chen; Yuanmei Chen; Xiane Peng; Kunshou Zhu; Yimin Lin; Qiaokuang Lin; Zhijian Hu
Journal:  Oncotarget       Date:  2016-11-15

8.  Solitary Celiac Lymph Node Metastasis Has a Better Long-Term Survival Compared With Solitary Mediastinal Lymph Node Metastasis in Esophagectomy of Esophageal Squamous Cell Cancer: A Propensity Score Matching Analysis.

Authors:  Kun-Kun Li; Tao Bao; Ying-Jian Wang; Xiao-Long Zhao; Jiang Long; Xian-Feng Xie; Wei Guo
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

9.  Esophageal cancer presenting as a brain metastasis: A case report.

Authors:  Aldo Spallone; Chiara Izzo
Journal:  Oncol Lett       Date:  2013-07-03       Impact factor: 2.967

10.  The role of the retinoblastoma protein-interacting zinc finger gene 1 tumor suppressor gene in human esophageal squamous cell carcinoma cells.

Authors:  Shangwen Dong; Peng Zhang; Shaojie Liang; Shuo Wang; Pei Sun; Yuanguo Wang
Journal:  Oncol Lett       Date:  2013-10-09       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.